Published in World J Gastroenterol on July 28, 2007
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery. Oncologist (2010) 1.72
A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. Oncologist (2010) 1.26
Colorectal carcinogenesis--update and perspectives. World J Gastroenterol (2014) 1.19
Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev (2010) 1.19
IRWRLDA: improved random walk with restart for lncRNA-disease association prediction. Oncotarget (2016) 0.96
Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression. BMC Cancer (2008) 0.94
Identification of novel small-molecule compounds that inhibit the proproliferative Kruppel-like factor 5 in colorectal cancer cells by high-throughput screening. Mol Cancer Ther (2009) 0.93
Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer. Br J Cancer (2013) 0.93
Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients. Cancer Epidemiol Biomarkers Prev (2010) 0.91
Differential colorectal carcinogenesis: Molecular basis and clinical relevance. World J Gastrointest Oncol (2010) 0.90
High MACC1 expression in combination with mutated KRAS G13 indicates poor survival of colorectal cancer patients. Mol Cancer (2015) 0.89
Prognostic biomarkers in colorectal cancer: where do we stand? Virchows Arch (2014) 0.87
Understanding the colon cancer stem cells and perspectives on treatment. Cancer Cell Int (2015) 0.86
Review of histopathological and molecular prognostic features in colorectal cancer. Cancers (Basel) (2011) 0.85
Overexpression of Evi-1 oncoprotein represses TGF-β signaling in colorectal cancer. Mol Carcinog (2011) 0.83
The BRAF mutation is associated with the prognosis in colorectal cancer. J Cancer Res Clin Oncol (2014) 0.82
Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis. Oncotarget (2016) 0.81
Presence of activating KRAS mutations correlates significantly with expression of tumour suppressor genes DCN and TPM1 in colorectal cancer. BMC Cancer (2009) 0.81
Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer. Oncotarget (2016) 0.79
Modifier-concept of colorectal carcinogenesis: lipidomics as a technical tool in pathway analysis. World J Gastroenterol (2010) 0.78
Grape compounds suppress colon cancer stem cells in vitro and in a rodent model of colon carcinogenesis. BMC Complement Altern Med (2016) 0.77
Relationship between MLH-1, MSH-2, PMS-2,MSH-6 expression and clinicopathological features in colorectal cancer. Int J Clin Exp Pathol (2015) 0.77
Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer. World J Gastroenterol (2015) 0.77
Association of global DNA hypomethylation with clinicopathological variables in colonic tumors of Iraqi patients. Saudi J Gastroenterol (2016) 0.76
Clinical implications of BRAF mutation test in colorectal cancer. Gastroenterol Hepatol Bed Bench (2013) 0.76
Dissecting characteristics and dynamics of differentially expressed proteins during multistage carcinogenesis of human colorectal cancer. World J Gastroenterol (2016) 0.76
Molecular characteristics of mismatch repair genes in sporadic colorectal tumors in Czech patients. BMC Med Genet (2014) 0.75
Triphala Extract Suppresses Proliferation and Induces Apoptosis in Human Colon Cancer Stem Cells via Suppressing c-Myc/Cyclin D1 and Elevation of Bax/Bcl-2 Ratio. Biomed Res Int (2015) 0.75
Polymorphism within the distal RAD51 gene promoter is associated with colorectal cancer in a Polish population. Int J Clin Exp Pathol (2015) 0.75
The consensus coding sequences of human breast and colorectal cancers. Science (2006) 60.02
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
The fundamental role of epigenetic events in cancer. Nat Rev Genet (2002) 30.05
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Genome maintenance mechanisms for preventing cancer. Nature (2001) 16.17
Microsatellite instability in cancer of the proximal colon. Science (1993) 14.51
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet (2006) 13.63
The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med (2000) 13.19
CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A (1999) 13.02
Mutations of mitotic checkpoint genes in human cancers. Nature (1998) 11.20
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med (2005) 9.39
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet (1998) 8.91
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (2000) 8.41
Mutator phenotype may be required for multistage carcinogenesis. Cancer Res (1991) 7.29
CpG island methylator phenotype in cancer. Nat Rev Cancer (2004) 7.13
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology (2005) 6.34
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res (2005) 5.68
Aneuploidy and cancer. Nature (2004) 5.61
Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol (2001) 4.90
Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc Natl Acad Sci U S A (2003) 4.76
Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev (2005) 4.27
CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology (2002) 3.70
Natural history of untreated colonic polyps. Gastroenterology (1987) 3.69
Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci U S A (2002) 3.57
Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res (1999) 3.48
High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology (2006) 3.24
Wnt signaling: complexity at the surface. J Cell Sci (2006) 3.11
CDC25 phosphatases as potential human oncogenes. Science (1995) 2.84
DNA microsatellite instability in hyperplastic polyps, serrated adenomas, and mixed polyps: a mild mutator pathway for colorectal cancer? J Clin Pathol (1999) 2.78
Molecular determinants of dysplasia in colorectal lesions. Cancer Res (1994) 2.62
Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res (1999) 2.54
Emerging concepts in colorectal neoplasia. Gastroenterology (2002) 2.44
The colorectal adenoma-carcinoma sequence. Br J Surg (2002) 2.39
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut (2002) 2.31
Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology (2001) 2.30
Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell (2003) 2.24
APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci U S A (1996) 2.18
Genomic instability and colon cancer. Cancer Metastasis Rev (2004) 2.15
APC and EB1 function together in mitosis to regulate spindle dynamics and chromosome alignment. Mol Biol Cell (2005) 2.14
Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol (2005) 2.08
B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway. Mol Cell Biol (1999) 1.99
Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol (1999) 1.98
p21(Waf1/Cip1) inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Mol Cell Biol (1999) 1.90
Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. J Clin Oncol (2003) 1.90
Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res (2001) 1.87
CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology (2004) 1.79
Misorientation and reduced stretching of aligned sister kinetochores promote chromosome missegregation in EB1- or APC-depleted cells. EMBO J (2006) 1.76
Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancer. Cancer Res (2002) 1.67
SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway. Proc Natl Acad Sci U S A (2001) 1.65
The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol (2003) 1.60
p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. Cancer Res (1998) 1.59
Prevalence of the mismatch-repair-deficient phenotype in colonic adenomas arising in HNPCC patients: results of a 5-year follow-up study. Int J Colorectal Dis (2006) 1.54
Microsatellite instability in colorectal cancer. Br J Surg (2006) 1.46
Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer (1999) 1.44
The centrosome--a tiny organelle with big potential. Nat Genet (1998) 1.34
HMSH6 alterations in patients with microsatellite instability-low colorectal cancer. Cancer Res (2000) 1.20
My approach to serrated polyps of the colorectum. J Clin Pathol (2004) 1.19
Colonoscopic screening of persons with suspected risk factors for colon cancer: II. Past history of colorectal neoplasms. Gastroenterology (1989) 1.07
Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol (2003) 1.07
Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome. Gut (1999) 1.06
Evolution of colorectal cancer: change of pace and change of direction. J Gastroenterol Hepatol (2002) 1.04
p53: link to the past, bridge to the future. Genes Dev (2005) 1.03
Microsatellite instability in aberrant crypt foci from patients without concurrent colon cancer. Carcinogenesis (2006) 0.89
Chromosomal instability and APC gene mutations in human sporadic colorectal adenomas. J Pathol (2004) 0.83
Adenoma screening and colorectal cancer. BMJ (1991) 0.76